Looking forward to participating at the Frontiers Showcase on May 09th! Endless Frontier Labs is such an enriching program, which we had the privilege of participating in during the 2021-2022 Life Sciences Cohort. Can't wait to hear about the exciting companies from this most

Please join us in congratulating three of our Onconauts on their recent promotions! 🥳🎉🧡

September is #BloodCancerAwarenessMonth 🩸🩸 linkedin.com/feed/update/ur…

We’re thrilled to have been awarded a Golden Ticket, which will cover a year’s rent for one of our Wet Lab Scientists at our New York HQ. Thank you Biolabs@NYULangone and NYCEDC for your support 🧡🏆🗽

We just wrapped up our Q4 Goal-Setting meeting at OncoPrecision. At the end of every quarter, each Team shares how they performed and what the key objectives for the coming quarter are. Q4 2024 is Q17 in the life of our company. Feeling humbled and tremendously optimistic 🧡🚀

October is #BreastCancerAwarenessMonth 🎀🎀 linkedin.com/feed/update/ur…

Happy birthday to us 🎂4️⃣🧡 Over the past weekend, we celebrated our 4th Birthday by reflecting on our achievements during these first 4 years in our story and on what we hope to accomplish in the years ahead.

Our Team wore pink for the #InternationalDayAgainstBreastCancer to raise awareness about breast cancer and promote early detection, diagnosis, and treatment 🩷🎀

Last Thursday, our Team participated in The Leukemia & Lymphoma Society Light the Night event in Manhattan's South Street Seaport. It was a powerful reminder of the importance of our work as we walked alongside an inspiring community of patients, survivors, and their loved ones 🧡🏮

This weekend, we’re presenting preclinical data from our #CMML & #AML programs at #ASH24 in San Diego. We’re proud to collaborate with experts from Mayo Clinic, MD Anderson Cancer Center, Discovery Life Sciences, and OncoPrecision. Read about our accepted abstracts: bit.ly/3OC7tUS

We’re thrilled to welcome Dr. Stefan Oschmann to our Advisory Board. Dr. Oschmann served as Chairman & CEO of Merck KGaA from 2016 to 2021, successfully leading the company through a period of transformation and growth. linkedin.com/feed/update/ur…

That’s a wrap! #ASH24

Some of this year’s #ASH24 highlights pictured: catching up with our dear Advisors (Dr. Dr. Gwen Nichols, Chief Medical Officer of The Leukemia & Lymphoma Society at their stand and Dr. Jorge Solimano, VP and Head of Hematology of CEMIC over lunch), our annual picture with the ASH sign, and a bit of fun.

Our CEO, Tarek Ali Zaki, will be participating in a panel discussion on Leveraging the Global Landscape: New Pathways and Geographies in Drug Development on January 15th hosted by SOSV - Deep Tech for Human and Planetary Health's IndieBio and LOTTE Ventures U.S. lu.ma/ew7dbw2n

Happy Holidays from the OncoPrecision Team!

On this hashtag#WorldCancerDay we stand united with patients, their families, and all lives that are touched by cancer, as we strive to advance much-needed transformative therapies 🧡

Please join us in congratulating our recently promoted Onconauts! 🎉🧡

OncoPrecision is heading to #BIO2025! We look forward to engaging with partners, industry leaders, and innovators to exchange ideas, explore strategic collaborations, and advance patient-centric drug discovery efforts for novel cancer therapies.

Blood cancers affect over 1.2 million people worldwide each year. This #BloodCancerAwarenessMonth, we are reminded of our commitment to raise awareness, support those impacted, and continue to push the boundaries of science so that every patient has a better tomorrow 🩸🧡

October is hashtag#BreastCancerAwarenessMonth — a reminder of courage, resilience, and the power of science to bring hope 🎀🎀 This month, we’re shining a light on the importance of regular screening, early detection, and continued innovation in the search for new treatments.